Jalan, R.; Sen, S.; Williams, R.
June 2004
Gut;Jun2004, Vol. 53 Issue 6, p890
Academic Journal
This article examines prospects for extracorporeal liver support. Liver failure, whether of the acute variety with no pre-existing liver disease, acute liver failure, or an acute episode of decomposition superimposed on a chronic liver disorder, carries a high mortality. However, liver failure, whether of the acute or acute on chronic variety, is potentially reversible, and considerable work has been carried out over many years to develop effective liver support devices. The development of these devices has been approached in different ways.


Related Articles

  • Management of Hepatic Encephalopathy. Wright, G.; Chattree, A.; Jalan, R. // International Journal of Hepatology;2011, p1 

    Hepatic encephalopathy (HE), the neuropsychiatric presentation of liver disease, is associated with high morbidity and mortality. Reduction of plasma ammonia remains the central therapeutic strategy, but there is a need for newer novel therapies. We discuss current evidence supporting the use of...

  • Cyborg Therapy. Stone, Andy // Forbes Asia;2/16/2009, Vol. 5 Issue 2, p74 

    The article focuses on an experimental machine that can temporarily take over liver function, developed by researchers at the University of Chicago Medical Center, Chicago, Illinois. The goal of the device is to take over enough liver function for a few days or weeks to keep patients alive until...

  • Artificial support systems for liver failure. Berk, Paul D.; Scharschmidt, Bruce F.; Martin, James F.; Plotz, Paul H. // Kidney International Supplement;Dec1976, Issue 7, p233 

    Presents a study which focus on artificial support systems for liver failure. Similarities in the role and function of the liver and kidneys; Examination on the necessary characteristics of an artificial device to perform the essential, life-saving functions of the failing liver; Proposal of...

  • Chronic Liver Disease Mortality Among Male Prison Inmates in Texas, 1989–2003. Harzke, Amy Jo; Baillargeon, Jacques; Paar, David P.; Pulvino, John; Murray, Owen J. // American Journal of Gastroenterology;Jun2009, Vol. 104 Issue 6, p1412 

    OBJECTIVES:Alcohol abuse and chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the major etiologic factors for chronic liver disease/cirrhosis (CLD) in the United States. These CLD risk factors are highly prevalent in US adult incarcerated populations, but CLD-related...

  • Fulminant Hepatitis in a Juvenile--onset Diabetic. Goldstein, Leonard I.; Lipitz, Lance; Niosi, Phillip; Trey, Charles // American Journal of Gastroenterology;Apr1970, Vol. 53 Issue 4, p352 

    Discusses a case of a juvenile-onset diabetic with fulminant hepatic failure that recovered from severe hepatic coma. Mortality rate of patients with fulminant hepatic failure associated with severe hepatic coma; Complications that resulted from hepatic failure; Forms of liver diseases wherein...

  • New Liver-Assist Device. March, Keith // Medical Update;2004, Vol. 29 Issue 11, p7 

    Announces the development of a liver-assist device by researchers at Cedars-Sinai Medical Center. Significance of the device to the mortality of patients suffering from acute liver failure; Functions of the filtering system of the device.

  • PORTOSYSTEMIC SHUNTS: FIVE- AND TEN-YEAR FOLLOW-UPS OF 68 CASES. Wratten, Gary P.; Jahnke, Edward J.; Whelan, Thomas J. // American Journal of Gastroenterology;May1964, Vol. 41 Issue 5, p519 

    Presents information on the long-term follow-up studies on patients undergoing portosystemic shunt procedures for intrahepatic portal obstruction. Description of the long-term effects of portosystemic shunt; Information on the survival and mortality rate of portosystemic shunt; Etiology of the...

  • Narrative Review: Hepatobiliary Disease in Type 2 Diabetes Mellitus. Tolman, Keith G.; Fonseca, Vivian; Tan, Meng H.; Dalpiaz, Anthony // Annals of Internal Medicine;12/21/2004, Vol. 141 Issue 12, p946 

    Diabetes mellitus is the fifth leading cause of death in the United States; 17 million people are affected. Liver disease is one of the leading causes of death in persons with type 2 diabetes. The standardized mortality rate for death from liver disease is greater than that for cardiovascular...

  • Role of the nurse in managing patients with hepatic cerebral oedema. McGuinness, Anna // British Journal of Nursing;3/22/2007, Vol. 16 Issue 6, p340 

    Acute liver failure occurs abruptly often without pre-existing liver disease being present. Management comprises support of the patient and treatment of symptoms until recovery or transplantation can occur. Cerebral oedema is one of the recognized complications of acute liver failure with a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics